These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34861136)

  • 1. IL-1β Promotes Expansion of IL-33
    Vu LD; Phan ATQ; Hijano DR; Siefker DT; Tillman H; Cormier SA
    Am J Respir Cell Mol Biol; 2022 Mar; 66(3):312-322. PubMed ID: 34861136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.
    Cormier SA; Shrestha B; Saravia J; Lee GI; Shen L; DeVincenzo JP; Kim YI; You D
    J Virol; 2014 Aug; 88(16):9350-60. PubMed ID: 24920801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.
    Russell RF; McDonald JU; Ivanova M; Zhong Z; Bukreyev A; Tregoning JS
    J Virol; 2015 Sep; 89(17):8974-81. PubMed ID: 26085154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jinxin oral liquid inhibits human respiratory syncytial virus-induced excessive inflammation associated with blockade of the NLRP3/ASC/Caspase-1 pathway.
    Shen C; Zhang Z; Xie T; Xu J; Yan J; Kang A; Dai Q; Wang S; Ji J; Shan J
    Biomed Pharmacother; 2018 Jul; 103():1376-1383. PubMed ID: 29864921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of uric acid or IL-1β ameliorates respiratory syncytial virus immunopathology and development of asthma.
    Schuler CF; Malinczak CA; Best SKK; Morris SB; Rasky AJ; Ptaschinski C; Lukacs NW; Fonseca W
    Allergy; 2020 Sep; 75(9):2279-2293. PubMed ID: 32277487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4Rα on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection.
    Shrestha B; You D; Saravia J; Siefker DT; Jaligama S; Lee GI; Sallam AA; Harding JN; Cormier SA
    J Leukoc Biol; 2017 Jul; 102(1):153-161. PubMed ID: 28389622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus upregulates IL-33 expression in mouse model of virus-induced inflammation exacerbation in OVA-sensitized mice and in asthmatic subjects.
    Nikonova A; Shilovskiy I; Galitskaya M; Sokolova A; Sundukova M; Dmitrieva-Posocco O; Mitin A; Komogorova V; Litvina M; Sharova N; Zhernov Y; Kudlay D; Dvornikov A; Kurbacheva O; Khaitov R; Khaitov M
    Cytokine; 2021 Feb; 138():155349. PubMed ID: 33132030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking of opioid receptors in experimental formaline-inactivated respiratory syncytial virus (FI-RSV) immunopathogenesis: from beneficial to harmful impacts.
    Salimi V; Mirzaei H; Ramezani A; Tahamtan A; Jamali A; Shahabi S; Golara M; Minaei B; Gharagozlou MJ; Mahmoodi M; Bont L; Shokri F; Mokhtari-Azad T
    Med Microbiol Immunol; 2018 Apr; 207(2):105-115. PubMed ID: 29256094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-Dioxygenase.
    Cheung MB; Sampayo-Escobar V; Green R; Moore ML; Mohapatra S; Mohapatra SS
    PLoS One; 2016; 11(10):e0163709. PubMed ID: 27695127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection.
    Sampayo-Escobar V; Green R; Cheung MB; Bedi R; Mohapatra S; Mohapatra SS
    PLoS One; 2018; 13(4):e0192709. PubMed ID: 29677209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated Leukocyte Cell Adhesion Molecule Regulates the Expression of Interleukin-33 in RSV Induced Airway Inflammation by Regulating MAPK Signaling Pathways.
    Baek SM; Kim MN; Kim EG; Lee YJ; Park CH; Kim MJ; Kim KW; Sohn MH
    Lung; 2024 Apr; 202(2):127-137. PubMed ID: 38502305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural helper cells are associated with the exacerbated airway inflammation seen during RSV reinfection of neonatally primed mice.
    Wu J; Hu H; Xu L; Qi F; Bai S; Cui Y; Chai R; Wang D; Liu B
    Int Immunopharmacol; 2017 Apr; 45():156-162. PubMed ID: 28219838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.
    Yang J; Ma C; Zhao Y; Fan A; Zou X; Pan Z
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.
    Harker JA; Godlee A; Wahlsten JL; Lee DC; Thorne LG; Sawant D; Tregoning JS; Caspi RR; Bukreyev A; Collins PL; Openshaw PJ
    J Virol; 2010 Apr; 84(8):4073-82. PubMed ID: 20130064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.
    Connors M; Giese NA; Kulkarni AB; Firestone CY; Morse HC; Murphy BR
    J Virol; 1994 Aug; 68(8):5321-5. PubMed ID: 8035532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus.
    Patel JA; Kunimoto M; Sim TC; Garofalo R; Eliott T; Baron S; Ruuskanen O; Chonmaitree T; Ogra PL; Schmalstieg F
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):602-9. PubMed ID: 7576697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.
    Foronjy RF; Dabo AJ; Cummins N; Geraghty P
    BMC Immunol; 2014 Oct; 15():41. PubMed ID: 25277705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.